594 related articles for article (PubMed ID: 30025377)
61. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier.
Attari E; Nosrati H; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of host-guest system to enhance the tamoxifen efficiency.
Heidari Majd M; Akbarzadeh A; Sargazi A
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):441-447. PubMed ID: 27012732
[TBL] [Abstract][Full Text] [Related]
63. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
[TBL] [Abstract][Full Text] [Related]
64. NIR and UV-responsive degradable hyaluronic acid nanogels for CD44-targeted and remotely triggered intracellular doxorubicin delivery.
Hang C; Zou Y; Zhong Y; Zhong Z; Meng F
Colloids Surf B Biointerfaces; 2017 Oct; 158():547-555. PubMed ID: 28743090
[TBL] [Abstract][Full Text] [Related]
65. Multifunctional self-assembled micelles of galactosamine-hyaluronic acid-vitamin E succinate for targeting delivery of norcantharidin to hepatic carcinoma.
Jiang S; Li M; Hu Y; Zhang Z; Lv H
Carbohydr Polym; 2018 Oct; 197():194-203. PubMed ID: 30007605
[TBL] [Abstract][Full Text] [Related]
66. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
67. Mitoxantrone-loaded chitosan/hyaluronate polyelectrolyte nanoparticles decorated with amphiphilic PEG derivates for long-circulating effect.
Wang J; Asghar S; Jin X; Chen Z; Huang L; Ping Q; Zong L; Xiao Y
Colloids Surf B Biointerfaces; 2018 Nov; 171():468-477. PubMed ID: 30077147
[TBL] [Abstract][Full Text] [Related]
68. Synthesis, characterization, and in vitro anti-tumor activity studies of the hyaluronic acid-mangiferin-methotrexate nanodrug targeted delivery system.
Wang H; Shao W; Lu X; Gao C; Fang L; Yang X; Zhu P
Int J Biol Macromol; 2023 Jun; 239():124208. PubMed ID: 36972827
[TBL] [Abstract][Full Text] [Related]
69. Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery.
Lin WJ; Lee WC; Shieh MJ
Carbohydr Polym; 2017 Jan; 155():101-108. PubMed ID: 27702492
[TBL] [Abstract][Full Text] [Related]
70. Ameliorative Effect of Curcumin-Encapsulated Hyaluronic Acid-PLA Nanoparticles on Thioacetamide-Induced Murine Hepatic Fibrosis.
Chen YN; Hsu SL; Liao MY; Liu YT; Lai CH; Chen JF; Nguyen MT; Su YH; Chen ST; Wu LC
Int J Environ Res Public Health; 2016 Dec; 14(1):. PubMed ID: 28029125
[TBL] [Abstract][Full Text] [Related]
71. Advances in Hyaluronic Acid-Based Drug Delivery Systems.
Jiao Y; Pang X; Zhai G
Curr Drug Targets; 2016; 17(6):720-30. PubMed ID: 26028046
[TBL] [Abstract][Full Text] [Related]
72. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
[TBL] [Abstract][Full Text] [Related]
73. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
[TBL] [Abstract][Full Text] [Related]
74. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
[TBL] [Abstract][Full Text] [Related]
75. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
Wei X; Senanayake TH; Warren G; Vinogradov SV
Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
[TBL] [Abstract][Full Text] [Related]
76. Fabrication and biological evaluation of chitosan coated hyaluronic acid-docetaxel conjugate nanoparticles in CD44(+) cancer cells.
Shabani Ravari N; Goodarzi N; Alvandifar F; Amini M; Souri E; Khoshayand MR; Hadavand Mirzaie Z; Atyabi F; Dinarvand R
Daru; 2016 Jul; 24(1):21. PubMed ID: 27473554
[TBL] [Abstract][Full Text] [Related]
77. A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Saraf SA
Drug Deliv Transl Res; 2019 Feb; 9(1):37-52. PubMed ID: 30178279
[TBL] [Abstract][Full Text] [Related]
78. Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44.
Spadea A; Rios de la Rosa JM; Tirella A; Ashford MB; Williams KJ; Stratford IJ; Tirelli N; Mehibel M
Mol Pharm; 2019 Jun; 16(6):2481-2493. PubMed ID: 31013093
[TBL] [Abstract][Full Text] [Related]
79. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
80. Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake.
Zheng S; Jin Z; Han J; Cho S; Nguyen VD; Ko SY; Park JO; Park S
Colloids Surf B Biointerfaces; 2016 Jul; 143():27-36. PubMed ID: 26998864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
